Professor Richard Russell: key facts
- Kind of voice
- Academic
- Role
- Professor of Respiratory Medicine at King's College London
- Quoted on
- Respiratory (asthma/COPD)
- Tracked press citations
- 2
- Most recently quoted
- 30 Sept 2026
- First quoted
- 10 Sept 2026
“Nucala's NHS use holds the potential to both improve outcomes and ease pressure on the healthcare system by reducing hospitalisations”
What Professor Richard Russell has said
“'This is a life-saving cultural shift in asthma care. With continued support for patients, we can further reduce preventable attacks and improve lives.'”
Chair of the British Thoracic Society · Respiratory (asthma/COPD) · 10 Sept 2026 · Over one million switched to combined asthma inhalers since NICE update ↗
Where Professor Richard Russell has been quoted
- GSK’s Nucala secures NICE COPD endorsementpharmaceutical-technology.com · 30 Sept 2026
- Over one million switched to combined asthma inhalers since NICE updatepulsetoday.co.uk · 10 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.